|
|
Article: PharmaFrontiers in-licenses T cell RA vaccine.(rheumatoid arthritis)(Shanghai Institute for Biological Sciences)(Brief Article)
- Article from:
- Pharma Marketletter
- Article date:
- January 30, 2006
CopyrightCOPYRIGHT 2006 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Texas, USA-based PharmaFrontiers, a specialist developer of cell therapies, says that it has acquired an exclusive worldwide license for an autologous T cell vaccine for rheumatoid arthritis developed by the Shanghai Institute for Biological Sciences, at the Chinese Academy of Science. The agreement includes all intellectual property rights and research results.
Early clinical trial data indicate that the vaccine induces immune responses that ...